Haleon plc ADR Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
9.6%projected annual EPS growth
Analyst Coverage
5analysts covering
FY Revenue (est.)
$15.3Bnext fiscal year
FY EPS (est.)
$0.77next fiscal year
Monitoring Framework
Key Performance Indicators
Organic Revenue Growth Annually300.0%Target: 4% to 6% annual organic revenue growth over the medium term
Adjusted Gross Profit Margin Expansion (at constant currency) Annually22,000.0%Target: 50 to 80 basis points on average per annum
Net Debt to Adjusted EBITDA Leverage Ratio QuarterlyTarget: Around 2.5x
Watch Items
- North American Cold and Flu Season SeverityTrigger: Significant volume/mix softness in Respiratory Health categoryAction: Re-evaluate full-year organic revenue growth guidance and adjust marketing spend allocation to stronger categories like Oral Health.
- Productivity Program Cost SavingsTrigger: Cumulative savings tracking below the GBP 800 million target by 2030Action: Review supply chain optimization, warehouse consolidation, and manufacturing footprint rationalization initiatives.
Research as of 2 Sep 2026